A breakthrough trial testing a new drug resulted in improved survival rates for dogs diagnosed with a cancer called hemangiosarcoma (HSA).
A breakthrough trial testing a new drug resulted in improved survival rates for dogs diagnosed with a cancer called hemangiosarcoma (HSA).